Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Calcium alginate/poly arginine-chitin glycan composite medicine release -controlled microcap sule and preparing method thereof

A technology of calcium alginate and polyarginine, which is applied in the directions of drug delivery, pharmaceutical formulations, and medical preparations with non-active ingredients to achieve a smooth surface

Inactive Publication Date: 2007-12-19
HUAQIAO UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The object of the present invention is to provide a calcium alginate / polyarginine-chitosan compound drug controlled release microcapsule and its preparation method, to overcome the shortcoming of film-forming by a single substance, and to improve the nutritional effect and pharmacology of the product function of interventional therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The following is the specific implementation steps of the present invention taking the two-component single-layer membrane composite microcapsule as an example (taking bovine hemoglobin as the representative of protein and polypeptide drugs as an example):

[0020] First, filter the 1.8% sodium alginate solution through 0.8 μm, 0.45 μm, and 0.22 μm, add bovine hemoglobin to make the content 1 mg / mL, mix well, remove bubbles by ultrasonic waves, transfer 4 mL into a syringe, The drop generator is dropped into 200mL of 1.5% (w / v) calcium chloride solution containing 0.2% Tween80 dispersant, and a gelation reaction occurs to form calcium alginate gel beads with a certain particle size.

[0021] Second, soak the prepared calcium alginate beads in 20 mL of 5 mg / mL bovine hemoglobin solution and let stand for adsorption for more than 12 hours.

[0022] Third, after the adsorbed beads were quickly washed twice with normal saline, 20 mL of a mixture containing 0.6% chitosan and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention refers to calcium alginate / PAA-chitosan compound drug controlled-release microcapsule and making method. The microcapsule is double-component single-layer film compound one or double-component double-layer film compound one. It uses static combination, uses PAA-chitosan as film material, and uses high-pressure static liquid drop generator to make the microcapsule, using sodium alginate to decorate surface, the particle size even and controllable, within 200-1000 mum, and the particle surface glabrous.

Description

technical field [0001] The invention relates to microcapsules with calcium alginate as gel beads and polyarginine-chitosan as capsule walls and a preparation method thereof, in particular to microcapsules and preparation methods for drug controlled release. Background technique [0002] Microencapsulation technology is a technology that completely encapsulates dispersed solid material particles, liquid droplets or gases in a film to form spherical microcapsules. Utilizing the functions of protecting and controlling substance diffusion of the microcapsule membrane, microcapsules have been widely used in the pharmaceutical industry, industry, agriculture and daily necessities, especially in drug controlled release systems. [0003] Chitosan has good biocompatibility and can be biodegraded, and the degradation products are non-toxic. Polyarginine and its degradation products not only have good biocompatibility and non-toxicity, but also can improve the immune function of wound...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/36A61K47/12A61K9/52
Inventor 王士斌翁连进陈爱政陈梅英
Owner HUAQIAO UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com